Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan

被引:0
|
作者
Mikhail G Dozmorov
Joseph T Azzarello
Jonathan D Wren
Kar-Ming Fung
Qing Yang
Jeffrey S Davis
Robert E Hurst
Daniel J Culkin
Trevor M Penning
Hsueh-Kung Lin
机构
[1] Oklahoma Medical Research Foundation,Arthritis & Clinical Immunology Program
[2] University of Oklahoma Health Sciences Center,Department of Urology
[3] University of Oklahoma Health Sciences Center,Department of Physiology
[4] University of Oklahoma Health Sciences Center,Department of Pathology
[5] Oklahoma City Department of Veterans Affairs Medical Center,Department of Biochemistry and Molecular Biology
[6] University of Oklahoma Health Sciences Center,Center of Excellence in Environmental Toxicology, Department of Pharmacology
[7] University of Pennsylvania School of Medicine,undefined
来源
BMC Cancer | / 10卷
关键词
Vascular Endothelial Growth Factor; Androgen Receptor; Vascular Endothelial Growth Factor Expression; LNCaP Cell; Vascular Endothelial Growth Factor mRNA Expression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Epigenetic control of cell phenotypes in the stem cell compartments of human prostate and prostate cancer: Implications for enhancement of prostate cancer therapies
    Maitland, Norman J.
    Pellacani, Davide
    Rane, Jayant K.
    Frame, Fiona M.
    Collins, Anne T.
    CANCER RESEARCH, 2014, 74 (19)
  • [22] AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
    Yuantong Tian
    Lijing Zhao
    Haitao Zhang
    Xichun Liu
    Lijuan Zhao
    Xuejian Zhao
    Yi Li
    Jing Li
    Diagnostic Pathology, 9
  • [23] SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion
    Mao, Lijun
    Yang, Chunhua
    Wang, Junqi
    Li, Wang
    Wen, Rumin
    Chen, Jiacun
    Zheng, Junnian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [24] SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion
    Lijun Mao
    Chunhua Yang
    Junqi Wang
    Wang Li
    Rumin Wen
    Jiacun Chen
    Junnian Zheng
    Journal of Translational Medicine, 11
  • [25] Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro
    Su, Wei-peng
    Sun, Li-na
    Yang, Shun-liang
    Zhao, Hu
    Zeng, Teng-yue
    Wu, Wei-zhen
    Wang, Dong
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2018, 32 (07)
  • [26] Prostate cancer targeting motifs: Expression of αvβ3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts
    Taylor, Robert M.
    Severns, Virginia
    Brown, David C.
    Bisoffi, Marco
    Sillerud, Laurel O.
    PROSTATE, 2012, 72 (05): : 523 - 532
  • [27] 14-3-3ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival
    Murata, Taro
    Takayama, Ken-ichi
    Urano, Tomohiko
    Fujimura, Tetsuya
    Ashikari, Daisaku
    Obinata, Daisuke
    Horie-Inoue, Kuniko
    Takahashi, Satoru
    Ouchi, Yasuyoshi
    Homma, Yukio
    Inoue, Satoshi
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5617 - 5627
  • [28] Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth
    Yepuru, Muralimohan
    Wu, Zhongzhi
    Kulkarni, Anand
    Yin, Feng
    Barrett, Christina M.
    Kim, Juhyun
    Steiner, Mitchell S.
    Miller, Duane D.
    Dalton, James T.
    Narayanan, Ramesh
    CLINICAL CANCER RESEARCH, 2013, 19 (20) : 5613 - 5625
  • [29] CONCURRENT TARGETING AR/AR VARIANTS AND AKR1C3 FOR ADVANCED PROSTATE CANCER THERAPY
    Armstrong, Cameron
    Ning, Shu
    Lou, Wei
    Evans, Christopher
    Li, Pui-Kai
    Gao, Allen
    JOURNAL OF UROLOGY, 2023, 209 : E489 - E489
  • [30] Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation
    Sun, Shao-Qian
    Gu, Xiaobin
    Gao, Xian-Shu
    Li, Yi
    Yu, Hongliang
    Xiong, Wei
    Yu, Hao
    Wang, Wen
    Li, Yingbo
    Teng, Yingqi
    Zhou, Demin
    ONCOTARGET, 2016, 7 (30) : 48050 - 48058